 HOUSTON, March 11, 2021 GLOBE NEWSWIRE -- Bio-Path Holdings, Inc., NASDAQ: BPTH, a biotechnology company leveraging its proprietary DNAbilizeTM liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced an upcoming virtual poster presentation at the 2021 American Association for Cancer Research AACR Annual Meeting, taking place April 10-15 and May 17-21, 2021. 